1. Home
  2. LPSN vs PMN Comparison

LPSN vs PMN Comparison

Compare LPSN & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LivePerson Inc.

LPSN

LivePerson Inc.

HOLD

Current Price

$2.39

Market Cap

32.3M

Sector

Technology

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$12.88

Market Cap

34.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPSN
PMN
Founded
1995
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
EDP Services
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.3M
34.6M
IPO Year
2000
2022

Fundamental Metrics

Financial Performance
Metric
LPSN
PMN
Price
$2.39
$12.88
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
N/A
$42.67
AVG Volume (30 Days)
153.8K
40.5K
Earning Date
03-12-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$249,838,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.39
$0.29
52 Week High
$7.54
$27.40

Technical Indicators

Market Signals
Indicator
LPSN
PMN
Relative Strength Index (RSI) 36.88 33.55
Support Level $0.83 $0.41
Resistance Level $3.43 $19.85
Average True Range (ATR) 0.17 2.24
MACD -0.01 -0.99
Stochastic Oscillator 6.04 5.07

Price Performance

Historical Comparison
LPSN
PMN

About LPSN LivePerson Inc.

LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: